This Series on “New Biomarkers in Non-communicable Diseases” is edited by Dr. Tatsuo Shimosawa from the International University of Health and Welfare, School of Medicine, IUHW Narita Hospital, Department of Clinical Laboratory,852 Hatakeda, Narita, Chiba 286-8520 Japan
Editorial on New Biomarkers in Non-communicable Diseases
Continuous effort—not strength or intelligence—is the key to unlocking our potential—Winston Churchill—we are still underway to find biomarkers in cardiovascular diseases
Review Article on New Biomarkers in Non-communicable Diseases
Clinical utility of tubular markers in kidney disease: a narrative review
Review Article on New Biomarkers in Non-communicable Diseases
Historical, present, and emerging biomarkers in hypertension: a narrative review
Review Article on New Biomarkers in Non-communicable Diseases
The role of albumin level in cardiovascular disease: a review of recent research advances
Review Article on New Biomarkers in Non-communicable Diseases
Circulating levels of lipoprotein lipase and glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1: new markers for cardiovascular diseases among noncommunicable diseases: a brief narrative review
Disclosure:
The series “New Biomarkers in Non-communicable Diseases” was commissioned by the editorial office, the Journal of Laboratory and Precision Medicine without any sponsorship or funding. Tatsuo Shimosawa serving as the unpaid Guest Editor for the series.